Clal Biotechnology Industries Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -0.033x

Clal Biotechnology Industries Ltd cash flow conversion efficiency. Based on the latest financial reports, Clal Biotechnology Industries Ltd (CBI) has a cash flow conversion efficiency ratio of -0.033x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.06 Million ≈ $-2.85K USD) by net assets (ILA32.60 Million ≈ $87.40K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Clal Biotechnology Industries Ltd (2006–2024)

Cash flow conversion efficiency of Clal Biotechnology Industries Ltd from 2006 to 2024. This chart illustrates how Clal Biotechnology Industries Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CBI live share price for real-time trading data and today's change.

Clal Biotechnology Industries Ltd Cash Flow Conversion Ratio Explained

Clal Biotechnology Industries Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Clal Biotechnology Industries Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clal Biotechnology Industries Ltd ranked by their cash flow conversion efficiency. Also see CBI company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
US Copper Corp V:USCU	-0.153x
Peruvian Metals Corp V:PER	-0.113x
Asra Minerals Ltd AU:ASR	-0.050x
SSH Group Ltd AU:SSH	0.196x
Bitterroot Resources Ltd V:BTT	-0.003x
Regentis Biomaterials Ltd. NYSE:RGNT	N/A
CHINA GREEN AGRIC.DL-001 F:GR0A	-0.015x
EAM Solar ASA OL:EAM	-0.355x

Annual Cash Flow Conversion Efficiency for Clal Biotechnology Industries Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Clal Biotechnology Industries Ltd from 2006 to 2024. Review Clal Biotechnology Industries Ltd (CBI) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA46.16 Million ≈ $123.77K	ILA-6.48 Million ≈ $-17.37K	-0.140x	-100.12%
2023-12-31	ILA121.41 Million ≈ $325.49K	ILA-8.51 Million ≈ $-22.82K	-0.070x	+82.79%
2022-12-31	ILA144.90 Million ≈ $388.46K	ILA-59.04 Million ≈ $-158.28K	-0.407x	-233.60%
2021-12-31	ILA338.37 Million ≈ $907.16K	ILA-41.33 Million ≈ $-110.80K	-0.122x	-88.87%
2020-12-31	ILA513.79 Million ≈ $1.38 Million	ILA-33.23 Million ≈ $-89.08K	-0.065x	-219.11%
2019-12-31	ILA497.85 Million ≈ $1.33 Million	ILA27.03 Million ≈ $72.46K	0.054x	+154.16%
2018-12-31	ILA867.62 Million ≈ $2.33 Million	ILA-86.98 Million ≈ $-233.19K	-0.100x	+11.36%
2017-12-31	ILA808.20 Million ≈ $2.17 Million	ILA-91.41 Million ≈ $-245.05K	-0.113x	+24.44%
2016-12-31	ILA752.50 Million ≈ $2.02 Million	ILA-112.63 Million ≈ $-301.97K	-0.150x	-11.24%
2015-12-31	ILA1.09 Billion ≈ $2.93 Million	ILA-147.00 Million ≈ $-394.10K	-0.135x	-46.12%
2014-12-31	ILA1.26 Billion ≈ $3.38 Million	ILA-115.95 Million ≈ $-310.86K	-0.092x	+14.64%
2013-12-31	ILA1.38 Billion ≈ $3.70 Million	ILA-148.98 Million ≈ $-399.40K	-0.108x	-85.31%
2012-12-31	ILA1.40 Billion ≈ $3.74 Million	ILA-81.22 Million ≈ $-217.75K	-0.058x	+37.01%
2011-12-31	ILA1.11 Billion ≈ $2.97 Million	ILA-102.45 Million ≈ $-274.67K	-0.092x	-1.22%
2010-12-31	ILA1.23 Billion ≈ $3.29 Million	ILA-111.93 Million ≈ $-300.07K	-0.091x	+17.70%
2009-12-31	ILA782.91 Million ≈ $2.10 Million	ILA-86.86 Million ≈ $-232.87K	-0.111x	+41.91%
2008-12-31	ILA274.45 Million ≈ $735.80K	ILA-52.41 Million ≈ $-140.52K	-0.191x	-25.63%
2007-12-31	ILA309.49 Million ≈ $829.73K	ILA-47.05 Million ≈ $-126.14K	-0.152x	+24.93%
2006-12-31	ILA116.28 Million ≈ $311.75K	ILA-23.55 Million ≈ $-63.13K	-0.203x	--

About Clal Biotechnology Industries Ltd

TA:CBI Israel Biotechnology

Market Cap

$9.63 Million

ILA3.59 Billion ILA

Market Cap Rank

#27037 Global

#382 in Israel

Share Price

ILA22.90

Change (1 day)

+0.88%

52-Week Range

ILA21.70 - ILA34.90

All Time High

ILA380.64